108MO Safety and efficacy outcomes with durvalumab after sequential chemoradiotherapy (sCRT) in stage III, unresectable NSCLC (PACIFIC-6)

M.C. Garassino, J. Mazieres, Martin Reck, C. Chouaïd, H. Bischoff, Niels Reinmuth, Laura Cove-Smith, T. Mansy, Diego Cortinovis, M.R. Migliorino, Angelo Delmonte, José García Sánchez, Luis Enrique Chara Velarde, Reyes Bernabé, L. Paz-Ares, I. Diaz Perez, Nataliya Trunova, K. Foroutanpour, Corinne Faivre‐Finn